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Abstract
Cell models for the study of antiproliferative and/or cytotoxic properties of engineered 
nanoparticles are valuable tools in cancer research. Several techniques and methods are 
readily available for the study of nanoparticles’ properties regarding selective toxicity 
and/or antiproliferative effects. Setting up of those techniques, however, needs to be care-
fully monitored. Harmonization of the wide range of methods available is necessary for 
assay comparison and replicability. Although individual or core laboratory capabilities 
play a role in selection and availability of techniques, data arising from cancer cell models 
are useful in guiding further research. The variety of cell lines available and the diversity 
of metabolic routes involved in cell responses make in vitro cell models suitable for the 
study of the biological effect of nanoparticles at the cell level and a valid approach for 
further in vivo and clinical studies. The present systematic review looks at the in vitro 
biological effects of different types of nanoparticles in cancer cell models.
Keywords: cancer, nanoparticles, organic, metallic, nanobiotechnology, cytotoxicity, 
antiproliferation
1. Introduction
Toxicity studies are needed for nanoparticles’ (NPs) intended application on biomedical ther-
anostics. Nanostructures are being designed and fabricated with a wide range of potentiali-
ties, including those in cancer therapeutics, medical imaging and diagnostics. Thus, research 
on cell models and in vivo toxicity is growing as the nanostructures that are being fabricated 
will find possible uses in biomedical, clinical medicine and health-related sectors. NPs have 
interesting physical-chemical properties that are of value when engineering drug delivery 
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systems, diagnostic platforms and nanotechnology-based imaging strategies. The high sur-
face-to-volume ratio of NPs allows the use of different molecules, such as those intended for 
targeted drug delivery [1]. The above properties, however, might render NPs a toxic in vitro 
and in vivo profile. Since many NPs are entering the health market, it becomes increasingly 
necessary to perform toxicological investigation along with NP fabrication.
Earlier and recent toxicity studies on human cell lines have found a range of nanostructures 
that might be selectively toxic for particular cellular lines, including cancerous ones [2, 3]. This 
selective toxicity against specific types of cancer is a promising research field with potential 
implications in (pro)diagnosis and therapeutics [4, 5]. Human cell models are available for a 
variety of malignancies, serving as suitable platforms for exploring antiproliferative and cyto-
toxic effects of nanostructures [6]. Data from cancer cell models and NP exposure are valu-
able for guiding and designing in vivo testing and, potentially, for developing new anticancer 
theranostic strategies [7].
In this review, we compile and discuss the findings of several recent works using cancer cell 
models and exploring selective NP toxicity and/or antiproliferative effects for potential thera-
peutic applications in cancer. We looked for particularly interesting scientific papers from 
indexed journals published within 2015–2017. The focus of this review is on methodological 
aspects of NP treatment on human cell–based models, i.e. viability assessment techniques, 
experimental design for investigation of mechanisms of cellular damage, cell culture pro-
tocols and NP stability assessment, including in biological media. Results of this review are 
presented by nature of NPs. Studies exploring new cell culture techniques for assessment of 
NP toxicity on cancer cell lines were also included.
2. Physicochemical characteristics of nanomaterials and their influence 
on toxicity
The potential for biomedical applications of several NPs is enormous. There are, however, 
several shortcomings regarding interactions of engineered NPs with biological environments. 
Toxicity concerns for NPs intended for use in biomedicine have limited their translation into 
clinical settings. NP properties such as size, surface-to-volume ratio, shape, surface function-
alization and stability on biological media, among others, have been demonstrated to influ-
ence the toxicological profile of the nanostructures and their biocompatibility in general [7, 8]. 
It has been also demonstrated that the level of toxicity varies depending upon cell type, which 
reflects on particular cell line biology and genetics [9].
Interactions of NPs inside a biological environment, e.g. eukaryotic cells, have been widely 
studied [10]. Proteins, lipids or any biomolecule may be absorbed by NPs, affecting not only 
the original synthetic structure but its biological effect. Assessing antitumor properties of 
NPs requires stability in investigation under in vitro cell culture conditions. The interactions 
between NPs and biomolecules present in the culture media, such as proteins and lipids, 
could change nanomaterial’s characteristics [12]. For instance, research has demonstrated the 
formation of protein corona around NP surface due to interaction with cellular media, result-
ing in modifications of their physical properties and leading, for instance, to aggregation and 
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sedimentation [13]. Thus, NP characterization during in vitro experiments is essential to 
understand the relationship between physical properties and mechanisms of in vitro toxicity.
In general, smaller NPs are more toxic than larger ones [14]. Several works have confirmed 
this relationship and some authors have identified NP sizes that correlate well with the level 
of toxicity observed on in vitro tests [15]. A range of toxic mechanisms leading to apoptosis, 
necrosis and genotoxicity is triggered by NPs of different range of dimensions. The net cyto-
toxic effect is usually cell and NP concentration dependent [9].
Several coating strategies have been tested for lowering the cytotoxic effects of many engi-
neered NPs intended for medical applications. Metallic NPs have been extensively inves-
tigated and are excellent candidates as drug nanocarriers, for imaging strategies and for 
immunological platforms in biomedicine [11]. Toxicity concerns have, however, slowed their 
faster development and translation. Green chemistry or biologically mediated synthesis of 
coated metallic NPs is on the rise, and consequently their nanotoxicity evaluation on biologi-
cal media has been pursued and published [15, 16].
Nanoparticles
Anticancer properties
Advantages Disadvantages
Metallic and nonmetallic 
nanoparticles
Naked [94, 95]
• High antitumor activity
•  Storage and release of 
energy to other molecules 
quite effectively
•  Improvement of sensitive 
single-molecule detection 
techniques
•  External stimuli 
responsive, e.g. light and 
magnetism modulate its 
activity
•  Tunable physical and 
chemical properties
• Conformational changes
• Coalescence
•  Stabilizers do not 
function properly in 
different solvents
•  In a large extent, 
synthesized with toxic 
chemicals for health and/
or environment
Coated [13, 16, 96]
•  Easy conjugation to 
drugs, proteins, and/or 
nucleotides
•  Attenuated cytotoxicity 
against normal cells due to 
surface functionalization
• Specific site of action
•  Biological effect varies 
among different coatings
•  Formation of a protein 
corona
•  Sedimentation and/or 
aggregation
Liposomes [96]
• High biocompatibility
•  Capability of conjugation 
with soluble and insoluble 
drugs
• Targeted drug release
• Low toxicity
•  Colloidal stability and 
biodegradability
•  Complex and expensive 
synthesis
Table 1. Advantages and disadvantages of (non)metallic nanoparticles and liposomes application in cancer research.
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Nanostructures such as semiconductor quantum dots (QDs) are also being investigated for 
biomedical purposes. Since the toxicity of these nanostructures is known, different coating 
procedures have been investigated in order to reduce their toxicity. For instance, zinc sulfide 
(ZnS) QDs functionalized with chitosan have shown no toxic effects on human leukocytes, 
contrary to the highly toxic cadmium sulfide (CdS) QDs that, even coated with biocompatible 
chitosan, showed to be toxic in a concentration and time-dependent manner [17]. A summary 
of the pros and cons of the use of NPs in cancer research is shown in Table 1.
3. The selective toxicity of nanomaterials on in vitro cancer cell models
Several mechanisms are involved in NP-mediated in vitro toxicity in normal (i.e. noncancerous) 
and cancerous cells. Cellular responses to NP exposure might include those at cell, organelle and 
gene level or a combination of them [18]. Direct cytotoxic effects might be apoptosis or necrosis 
(or both) mediated, with a number of mechanisms leading to cell death, changes in proliferation 
patterns and effects on cell differentiation. High levels of reactive oxygen species (ROS) produc-
tion, downregulation of antioxidant enzyme coding genes, lipid peroxidation and genotoxic 
effects, among others, may be involved in the integrated cellular response to NPs [19, 20].
In spite of the number of studies providing useful information on nanotoxicological profiling, 
there remains particular information with regard to cell-NP specificity interactions. In addition, 
investigation on the toxicity of nanostructures and biointeractions rely on data from a wide vari-
ety of experiments with several different methods and techniques that are chosen on the basis 
of laboratory capabilities and researchers´ technical expertise [21, 22]. Then, there are, as today, 
no standard cell panels or defined protocols available for assessment of cancer cell responses to 
NPs; therefore, data arising from those studies are difficult to compile and integrate. Moreover, 
there is still the risk that the toxicological picture from a particular study on specific NPs and 
cell lines might not be “complete” enough and that toxic risks may be overlooked.
Apoptosis is a common response of cells to NP treatment. Azizi and colleagues found that 
albumin-coated silver NPs (AgNPs) LD50 were several times lower for breast cancer cells 
than for normal white blood cells. Apoptosis assays such as Annexin V and microscopy 
counts of apoptotic bodies demonstrated that albumin-coated AgNPs exert proapoptotic 
selective effects on breast cancer cells while normal blood cells remained viable at the tested 
concentrations and times of exposure [5].
In a recent work on several murine cancer cell lines, Namvar and colleagues investigated the 
antitumor properties of biosynthesized zinc oxide NPs (ZnONPs). They found that cancer cell 
proliferation was inhibited by NPs in a time- and concentration-dependent manner and that 
the mechanism of cell death was primarily apoptosis via procaspases activation and intrinsic 
mitochondrial pathway triggering [2].
NP exposure may cause cancer cell death by oxidative stress through varied mechanisms, 
including ROS production, inhibition of antioxidant enzymes, mitochondrial damage and lipid 
peroxidation [20]. For instance, Matulionyte, et al. demonstrated that photoluminescent gold 
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nanoclusters have specific toxicity against MCF-7 breast cancer cells and were less toxic on 
MDA-MB 231 breast cancer cells, a highly drug-resistant cell line. The mechanism of cell death 
was apoptosis, necrosis and generation of ROS, effects that were more evident in MCF-7 cells [23].
Several other mechanisms are involved in the selective toxicity of NPs against different cancer 
cell lines. Endoplasmic reticulum (ER) autophagy is a well-known process related with NP 
exposure. A study by Wei, et al. found that silica NPs (SiNPs) induced ER autophagy in colon 
cancer cells. The authors showed a time-dependent effect of NP exposure, but interestingly, 
autophagy was present only at either low or high NP concentrations [24].
Due to the complexity of cell responses to NPs, it is important to evaluate the biological effect of 
NPs from different perspectives, from toxicology assessment to both in vitro and in vivo testing, 
to better understand NP-induced cellular responses and the mechanisms behind them (Figure 1).
Figure 1. Schematic interpretation of nanoparticle (NP) cellular effects. NPs undergo internalization by nonspecific or 
specific endocytosis and remain in the cytoplasm or inside intracellular vesicles, either individually or in aggregates. 
NPs might release ions that enter the nucleus and cause DNA fragmentation/hypermethylation and/or cell cycle arrest 
in cancer cells. Furthermore, NPs’ inhibitory effect on cellular viability is due to downregulation of antiapoptotic genes, 
e.g. Bcl2, generation of reactive oxygen species (ROS), mitochondria fission and autophagy and events that finally induce 
cell death through apoptosis. NPs could decrease the expression of transcription factors involved in stemness and thus 
inhibit angiogenesis.
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In the following sections, we discuss the cytotoxic and antiproliferative in vitro properties of 
different types of NPs and their potential application in nanotherapeutics.
3.1. Metallic nanoparticles: noble metals and selective antitumor properties
Inorganic nanostructures exhibit interesting physical properties such as magnetism, fluo-
rescence and localized surface plasmon resonance, which in combination with NPs’ small 
dimensions make them suitable for biological applications. An advantage over other types 
of nanostructures is that inorganic NPs could respond to external stimulation with light or 
magnetic fields [1]. Among inorganic NPs, noble metals have been commonly used for the 
synthesis of nanomaterials. For instance, silver, gold and platinum NPs are of interest in can-
cer research as multifunctional anticancer agents due to their particular properties [25, 26]. In 
the subsequent sections, antitumor properties of noble metallic NPs are discussed focusing on 
their in vitro effects on several cancer cell lines.
3.1.1. Silver nanoparticles
Silver nanoparticles (AgNPs) possess particular physicochemical properties that determine 
their extent of cytotoxicity in biological systems [27]. It is well documented that AgNPs exert 
an antiproliferative effect on cancer cell lines [19, 28]. According to Choi, et al., AgNPs develop 
a potential cytotoxic effect on A2780 ovarian carcinoma cells and ovarian cancer stem cells 
(OvCSCs) at high concentrations. The inhibitory effect on cellular viability is caused by the 
upregulation of p53 and caspase-3 genes. In contrast, AgNPs might promote cell proliferation 
at low concentrations. The relevance of these findings is that OvCSCs present more sensitivity 
to the treatment with AgNPs, which is particularly interesting due to the fact that CSCs might 
increase the risk of acquired resistance to chemotherapy [19].
The therapeutic effect of AgNPs in multidrug resistant (MDR)-cancer cells has also been 
investigated. Kovacs, et al. demonstrated that AgNPs induce apoptosis-mediated cell death 
in drug-sensitive (Colo 205) and drug-resistant (Colo 320) colon adenocarcinoma cell lines, 
in a dose-dependent manner [28]. The internalization of AgNPs was observed in both cell 
types; thus, they remained in the cytoplasm. In addition, AgNPs may act synergistically 
with anticancer drugs to enhance their tumor-killing effects in MDR cells due to their capa-
bility of modulating efflux activity [28]. It is important to highlight the risk of exposing 
normal cells to AgNPs. To illustrate, a hippocampal neuronal cell model (HT22) was treated 
with AgNPs, obtaining a decrease in cell viability, oxidative damage and hypermethylation 
in DNA due to the internalization of AgNPs. These effects in normal cells may be prolonged 
since harmful impacts remain after AgNP removal [29]. Similar reports were found by Gao, 
et al., demonstrating that AgNPs can potentially damage mouse embryonic stem cells [30]. 
A novel approach to reduce cytotoxicity against normal cells is the functionalization or 
modification of AgNP surface [16]. Extensive research has been conducted to validate the 
hypothesis that AgNPs could inhibit angiogenesis, a complex process that is involved in the 
formation of new blood vessels and tumor progression [31]. For instance, Gurunathan, et al. 
concluded that the treatment of bovine retinal endothelial cells (BRECs) with AgNPs might 
activate PI3K/Akt pathway resulting in the inhibition of capillary formation [32]. Based on 
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this evidence, AgNPs are potent antineoplastic agents with acute cytotoxic effects that mod-
ulate several metabolic pathways leading to decreased cell viability, independently or in 
combination with other anticancer drugs. This synergistic effect will be further discussed 
along this chapter.
3.1.2. Gold nanoparticles
Compatibility of gold with biosystems has been well demonstrated since metallic nanoscale 
materials were originally developed [33]. In recent years, synthesis and application of gold 
NPs (AuNPs) in the biomedical field have substantially increased due to their ductility physi-
cochemical properties and biocompatibility. AuNPs can be synthesized in different shapes 
including spheres, rods, cubes, triangles, cones and shells [34]. Therefore, based on their size 
and shape, “naked” AuNPs possess several applications, e.g. as antitumor agents, drug nano-
carriers, hyperthermia enhancers and radio sensitizers [1, 35].
AuNPs exert in vitro cytotoxicity on several human cancer cell lines including cervical (HeLa), 
prostate (PC-3), hepatocellular carcinoma (HepG2) and breast cancer (MDA-MB-231) [3, 36–
38]. Wozniak, et al. proved that spherical and rod-shaped AuNPs are more efficient than other 
shapes in reducing cell proliferation of cancer cells in vitro [36]. Positively charged naked 
AuNPs interact with negatively charged cell membranes, increasing cellular uptake, pref-
erably with smaller diameter particles rather than larger ones [37]. Also of interest, AuNPs 
can be used in combination with other anticancer molecules. For instance, Ke, et al. reported 
that AuNPs improved the responsiveness of Calu-1 epidermoid carcinoma cell line to 
tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) [39]. This combined 
approach induced DNA fragmentation, mitochondrial fission and a decrease in cell viability 
due to apoptosis. By contrast, the effect on cell viability was minimal in the BEAS-2B normal 
lung cell line [39].
In addition, AuNPs could act as enhancers of hyperthermia-targeted therapy because they 
efficiently absorb laser light and convert it into thermal energy [40]. The synergistic effect of 
AuNPs and laser-induced thermotherapy renders thermally exposed cancer cells susceptible 
to be ablated with minimal exposure times and lower laser intensities [33]. Rau, et al. showed 
that AuNPs could cause severe damage in the cytoskeleton of MG63 osteosarcoma cells in 
combination with laser treatment, increasing the calcium content inside the cells and leading 
to mineralization [41]. Another technique to induce hyperthermia in tumors is directed ultra-
sound. Kosheleva, et al. discovered that the combined treatment of ultrasound and AuNPs 
exerted a more acute cytotoxic effect on A549 lung cancer cells compared to BEAS-2B normal 
lung cells when cultivated separately and in coculture [42]. These findings suggested that 
AuNP-assisted thermotherapy could cause targeted cancer cell ablation, while avoiding dam-
age to surrounding noncancerous cells.
AuNPs can be uptaken by cancer cells via endocytosis and trigger apoptotic events [43]. As a 
consequence, an improvement in radiation therapy has been observed when cancer cells are 
previously exposed to AuNPs [43]. Likewise, high atomic number in AuNPs increases radia-
tion absorption from the target tumor [43]. Literature suggests that AuNPs act as radiosensi-
tizers in several cancer cell lines, such as U251 glioblastoma, which in clinical practice could 
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increase radiotherapy efficacy and prevent the development of drug-resistant tumors [44]. 
Another approach thoroughly studied by Rezaee, et al. showed that electroporation enhances 
radiosensitizing effect of AuNPs in HT-29 colon adenocarcinoma cells as a result of increasing 
cell membrane permeability. In this study, AuNPs’ radiosensitizing effect was more promi-
nent in cancer cells than in normal counterparts [43].
3.1.3. Platinum nanoparticles
Several investigations have addressed the antiproliferative effect of platinum nanoparticles 
(PtNPs) in cell models [45–48]. Bendale, et al. concluded that the harmful effect of PtNPs 
on cancer cell viability depends on the cell type. At the same PtNP concentration, an acute 
cytotoxic effect was observed in lung (A549), ovary (PA-1) and pancreatic (Mia-Pa-Ca-2) can-
cer cells [45] . In this study, no significative effect on cell viability was observed in breast, 
renal, colon and leukemia cancer cell lines. Interestingly, peripheral blood mononuclear cells 
(PBMCs) were not affected either, suggesting that PtNPs could preferably target tumor cells 
[45]. According to Kutwin, et al., PtNPs severely affect the proliferation rate and morphology 
of U118 and U87 human malignant glioma cell lines, and as a consequence, cells suffer from 
membrane disruption, reduced density and decreased migration [46]. Gehrke, et al. did not 
find any adverse effect on cellular viability when HT29 colon carcinoma cells were treated 
with PtNPs. It was observed, however, that smaller PtNPs enter the cells and remain in the 
cytoplasm or inside intracellular vesicles, either individually or in aggregates. Additionally, 
PtNPs released Pt ions that may bind to DNA leading to strand cleavage damage [49]. 
Another important feature is the synergistic antitumor activity between platinum and gold 
NPs. Ahamed, et al. reported that platinum-coated gold nanorods (AuNRs-Pt) affected cell 
viability on MCF7 breast cancer cells at relatively low doses. The mechanism of action of 
AuNRs-Pt involved impairment of normal morphology resulting in rounded cells, cell cycle 
detention at SubG1 phase, increased expression levels of proapoptotic genes caspase-3 and 
caspase-9 and generation of ROS [47]. Manikandan, et al. demonstrated that PtNPs could 
improve photothermal treatment in cancer cells. Neuro-2a brain neuroblastoma cells were 
exposed to the combined scheme of laser irradiation and PtNPs, which resulted in induction 
of apoptosis [48]. There was no significative effect on cellular viability when PtNPs and laser 
treatment were applied separately [48].
3.1.4. Other metal-based nanomaterials
Titanium dioxide (TiO
2
), zinc (Zn), copper (Cu) and iron (Fe) are used in several industrial 
applications such as cosmetics, paint chemicals, food additives, pharmacological coatings, 
drug delivery systems, biosensor technologies and body implants. These nanomaterials have 
been also tested in cancer research and development of new therapeutics [22, 50].
Xia and coworkers reported the cytotoxic effect of cuprous oxide nanoparticles (CONPs) on 
HeLa, SiHa and MS751 human cervical cancer cell lines. Results demonstrated that CONPs 
are uptaken by cells and internalized into the cytoplasm, mitochondria and lysosomes; as a 
result, cell morphology alterations and decreased cellular viability were observed. Cell cycle 
arrest in the G1/G0 phase, induction of apoptosis and autophagy were also reported [51].
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The antineoplastic effect of CONPs in PC-3, LNCaP FGC and DU145 human prostate car-
cinoma cells was investigated by Wang, et al. The results of this study suggest that CONPs 
might induce cytotoxicity selectively on cancerous cells without affecting normal prostate 
epithelial cells (RWPE-1). Moreover, a significant decrease in the expression of Oct4, Sox2 and 
KLF4 transcription factors related with stem-cell proliferation capability was observed [52].
Superparamagnetic iron oxide nanoparticles (SPIONs) are also included in a large extent 
in nanomedical products [1]. SPIONs develop magnetic properties within a magnetic field; 
therefore, they are able to act in specific target sites [1]. Several studies demonstrated that 
SPIONS can be approached as hyperthermia enhancers, contrast agents in magnetic reso-
nance imaging, drug nanocarriers and anticancer candidates [1]. For instance, Du, et al. stud-
ied the combined effect of SPIONs and spinning magnetic field (SMF) on the survival rate 
of U-2 OS and Saos-2 osteosarcoma cell lines. This combined treatment exerts a more effec-
tive cytotoxic response triggering the intracellular ROS generation, autophagic cell death and 
apoptosis, than SPION treatment alone [53].
3.2. Nonmetallic and organically coated metallic nanomaterials: antiproliferative and 
cytotoxic properties
3.2.1. Green synthesis–based nanomaterials
Production of materials at the nanometric scale (1–100 nm) has been performed using several 
approaches [54]. The most common synthesis method involves the use of three elements: cap-
ping agent, reducing agent and solvent [54]. However, most of these elements are toxic, flam-
mable, corrosive and even dangerous for the natural environment and living organisms. For 
this reason, a new green chemistry tendency emerged in the nanotechnology area to modify 
chemical processes and reduce or minimize the use of hazardous reagents [55]. The green-
synthesis approach has been focused on finding nontoxic elements to develop a more eco-
friendly design with improved efficiency [54]. Some of these new techniques require the use 
of solvents such as water, supercritical CO
2
 or ionic liquids [56, 57]. For example, silver and 
gold nanoscale structures, due to their chemical and biological properties, have been widely 
used in green synthesis in combination with medicinal plants (photosynthesis) or bacterial/
fungi/viral proteins (microbial-synthesis) [58]. This section provides further interesting exam-
ples of green-synthetized nanomaterials.
3.2.1.1. Photosynthesis
The importance of developing an alternative nanosynthesis protocol is not only for an envi-
ronmental footprint reduction, but contributes also for the simplification of industrial produc-
tion with the lack of expensive organic solvents and toxic chemicals [59]. The use of innocuous 
plant extracts with solvents such as water facilitates the production and further evaluation of 
green nanomaterials, which are fundamental for biological applications in critical areas e.g. 
drug production [59]. There are several nanoscale structures coated with plant extracts and 
their effect on living systems has been extensively studied [60]. For instance, Krishnaraj, et al. 
reported that Ag/Au biosynthesized NPs with Acalypha indica extract exerted a cytotoxic effect 
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in MDA-MB-231 human breast cancer cells. These NPs exhibited a proapoptotic effect through 
caspase-3 activation [58]. Another example of naturally coated AgNPs includes the effect of 
the Erythrina indica extract causing a dose-dependent reduction of viability in MCF7 breast 
cancer cells and HepG2 hepatocellular carcinoma [27]. The authors also demonstrated high 
antimicrobial activity for AgNPs against Staphylococcus aureus, Micrococcus luteus, Escherichia 
coli, Bacillus subtilis, Salmonella typhi and Salmonella paratyphi [27]. Moreover, AgNPs were syn-
thesized using Albizia adianthifolia leaf extract; the AgNP analysis determined the presence of 
saponins and glycosides as stabilizing agents [61]. Toxicity analysis was performed on A549 
lung cancer cells and normal peripheral lymphocytes [61]. The results showed a reduction 
in A549 cellular viability to 21% at 10 g/mL and 73% at 50 g/mL after 6 h of exposure [61]. In 
comparison, proliferation rates for normal cell lines were not altered [61]. Other applications 
of these nanostructured particles for disease treatment include antidiabetic effects, described 
with Cassia fistula AuNPs that reduce glucose levels in rats with streptozotocin-induced dia-
betes [62], and antimosquito larvicidal activity of Nelumbo nucifera AuNPs [63].
3.2.1.2. Microbial synthesis
Bacterial survival in the presence of heavy metals is caused by a transformation (reduction/pre-
cipitation) of metal ions into insoluble nontoxic metal nanoclusters. These detoxification reac-
tions are mediated by intracellular accumulation or a physicochemical process–denominated 
extracellular biosorption, which facilitates the concentration of contaminants, e.g. heavy met-
als, and binds them in their cellular structure, with variable levels of dispersity [64]. Based on 
these bacterial properties, Klaus, et al. described AgNP production in Pseudomonas stutzeri. This 
bacterium reduces silver ion to generate Ag0 and AgS
2
 NPs of different shapes and sizes located 
around the cellular poles [65]. Another interesting example is B. subtilis that reduces Au3+ to a 
neutral nanocompound (Au0) [66]. Moreover, production of lipopolysaccharides and phospho-
lipids in some bacteria mediates bioreduction, e.g. transformation of chloroauric acid (HAuCl
4
) 
to AuNPs in E. coli DH5α [64]. Nonetheless, assembly of microbial NPs is also performed in 
several fungi species such as Penicillium chrysogenum, which has showed to be an AuNP pro-
ducer in HAuCl
4
 solution [67]. Another remarkable study optimized nanowire production with 
M13 virus as biotemplate for development of lithium batteries [68]. Based on this informa-
tion, affordable and massive industrial production should be feasible with the use of biological 
nanofactories such as the above-mentioned examples. However, the lack of complete under-
standing of the molecular reaction mechanism is a major disadvantage of this methodology.
3.2.2. Organically coated metallic and nonmetallic nanomaterials
Nanobiotechnology as a mature biomedical field emerged in the last years [69]; for example, 
from gene-delivery systems to targeted drug delivery, it has several applications in cancer 
treatment, diagnosis (biomarkers), molecular biology and genetic/cell engineering [70, 71]. 
A nanomedicine-based therapeutic approach might be built on nanocarriers, e.g. liposomes 
and NPs that improve chemotherapeutic biodistribution [72] and have been useful for treat-
ing diseases such as cancer [73] and microbial infections [74]. In 1989, Matsumura and Maeda 
described the enhanced permeation and retention (EPR) effect, a controversial concept based 
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on the passive accumulation of macromolecular drugs in tumors due to the presence of a high 
number of abnormal blood vessels (angiogenesis), which lack lymphatic drainage, affecting 
in turn as a drug delivery system [75]. Despite the fact that this effect has been extensively 
studied but has failed in clinical trials [76], EPR is still one of the most used concepts in nano-
biodistribution [76]. With this information in mind, this section discusses relevant aspects 
of metallic and nonmetallic coated nanomaterials, including liposomes as novel therapeutic 
agents for cancer.
3.2.2.1. Organically coated nanomaterials
Organic coating is used to stabilize NPs and maintain a balance between electrostatic and 
electrosteric repulsion forces [73]. NPs of different shapes might be covered with diverse cap-
ping agents such as citric acid, polysaccharides, surfactants, proteins, polymers and nucleic 
acids [77, 78]. However, despite the fact that they have the same core material, coated-NPs 
exert different biological responses. For instance, viability, genotoxicity and mutagenicity 
evaluation of AgNPs coated with anionic (citrate, SDS), neutral (disperbyk, tween) or cationic 
(byk and chitosan) compounds were performed by Kun, et al. using lymphoblast TK6 cell line 
and Chinese hamster lung fibroblasts. The methodology used for testing involved trypan blue 
exclusion assay, relative growth activity, cell morphology, HPRT mutation and comet assay. 
The results determined that AgNPs_byk and AgNPs_chitosan were the most cytotoxic, affect-
ing cell morphology, inhibiting proliferation and inducing cell death through apoptosis or 
necrosis. Furthermore, AgNPs_byk showed significant mutagenic effects by inducing DNA 
strand breaks and oxidation. It is important to note that AgNPs_byk formed the smallest 
agglomerates in medium solution in comparison to other coated AgNPs, suggesting that size 
is an important factor in toxicity. To sum up, coated NPs display various biological in vitro 
effects depending mainly on their surface charge [12].
One of the well-known NP biointeractions is that with bovine serum albumin (BSA), which 
relies on principle that a protein corona is dynamically formed around NPs when they enter a 
biological environment [79]. A recent investigation performed by Zhou, et al. determined that 
ZnONPs bound to BSA elicited interleukin-6 (IL-6) production-mediated anti-inflammatory 
responses in HepG2 liver cancer cell line. Additionally, synthesized NPs induced mitochon-
dria and lysosomal damage by increasing intracellular Zn ions production [79]. However, 
the analysis of the biological effect of ZnONPs bound to α-linolenic acid (LNA) did not show 
the same response [79]. Another interesting example is the evaluation of the response of 
SPIONs conjugated to the antitumor peptide ATWLPPR (A7R) on HUVEC human umbili-
cal vein endothelial cells and MDA-MB-231 human breast adenocarcinoma [11]. These NPs 
might be adjusted carriers for targeted drug delivery systems using their magnetic properties. 
Furthermore, the presence of cell receptors for the A7R peptide facilitates the uptake of the 
nanocarriers. This is particularly important because the role of the receptor is to repress the 
vascular endothelial growth factor A (VEGF A). Consequently, NPs affect angiogenic events 
and impair cell proliferation [11].
The study of commercial anticancer drug formulations in nanoform has also been evalu-
ated, with positive results in many cases. For instance, tamoxifen, an anticancer agent used 
Cytotoxic and Antiproliferative Effects of Nanomaterials on Cancer Cell Lines: A Review
http://dx.doi.org/10.5772/intechopen.71685
73
in estrogen receptor-positive (ER+) breast cancer, has been commonly used before surgery to 
reduce tumor volume [80]. However, tamoxifen resistance has become a significant problem 
in cancer treatment [80]. Devulapally, et al. synthesized biodegradable polymer NPs loaded 
with the active compound of tamoxifen (4-hydroxytamoxifen-4OHT) and the noncoding RNA 
(anti-miR-21). NPs showed antiproliferative and proapoptotic effects in human breast (MCF7, 
ZR-751, BT-474) and mouse mammary (4 T1) carcinoma cells [81].
3.2.2.2. Nonmetallic nanomaterials
Despite the fact that most widely used nanomaterials have metal cores, a number of industry-
relevant nonmetallic nanoscale particles such as SiO
2
 and carbon NPs have been engineered. 
For instance, silica NPs have been extensively used in food additives [82], toothpaste and skin 
care products [83]. However, their use requires toxicology screening to determine their inno-
cuity. According to Wittig, et al., commercially available nanosilica (Ø 12 nm) increases the 
growth of GXF251L human gastric carcinoma cells. The results showed an important prolif-
erative effect through the activation of cellular epidermal growth factor receptor (EGFR) and 
mitogen-activated protein kinase (MAPK) signaling pathways [84].
On the contrary, research on antiproliferative properties have found that cerium oxide nano-
crystals (nanoceria: CeO
2
-NCs) can act as an anticancer drug [85]. The investigation conducted 
by Khan, et al. found that fluorescence microscopy assessments of nanoceria displayed a 
marked in vitro cytotoxic effect and reduced cellular viability on HT-29 human colorectal ade-
nocarcinoma. The results showed downregulation of Bcl2 and BclxL protein expression sug-
gesting proapoptotic effects. Additionally, this study confirmed previous reports [86] where 
cerium oxide exhibited a cytotoxic effect toward cancer cells with minimum toxicity to normal 
cells [86]. Another interesting example involved the evaluation of cytotoxic effects of smart-
releasing NPs synthesized using cytochrome C (Cyt C) and hyaluronic acid (HA) [87]. This 
study, by Figueroa, et al., showed that A549 human lung adenocarcinoma cellular viability 
was reduced to 20% (0.16 mg/mL [Cyt C], 6 h of exposure), while OS-7 African green monkey 
kidney fibroblasts were not affected. Confocal microscopy imaging confirmed the release of 
Cyt C to the cytoplasm upon reaching the target. In this study, EPR effect is used to develop 
a new potential stimuli-driven nanoparticle for cancer treatment [87].
Liposomes were firstly described in the middle 1960s as spherical vesicles constituted with 
phospholipid bilayers [88]. These lipid-based nanoparticles have been used in several fields 
from biophysics to biology for many years [88]. With the advances of nanotechnology, lipo-
somes have evolved in order to assure controlled delivery of active molecules to a specific site 
of action. For instance, a radiation therapy scheme in use for more than 50 years is boron neu-
tron capture (BNCT), which is based on the specific delivery of the isotope (boron-10) under-
going a nuclear reaction to form boron-11, through exposure to a laser beam (neutron source 
[89]). This reaction causes a release of an -particle that has a high linear energy transfer (LET) 
and kills the equivalent of one cell diameter [89]. In the above research, conducted by Maitz, 
et al., the effect of unilamellar liposomes (composed of cholesterol, 1, 2-distearoyl-sn-glycero-
3-phosphocholine, K [nido-7-CH
3
 (CH
2
)15-7, 8-C
2
B
9
H
11
] and core Na
3
 [1-(2′-B10H9)-2-NH3B10H8]) on mice bearing tumors (breast carcinoma EMT6 and colon carcinoma CT26) was studied. 
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Type Nanoparticles Coating material Cell type Biological effect Ref.
Metallic AgNPs Naked A2780 ovarian carcinoma Cytotoxic
[19]
OvCSCs ovarian cancer stem cells
Colo 205 colon adenocarcinoma Proapoptotic, synergic with anticancer drugs [28]Colo 320 drug-resistant colon adenocarcinoma
HT22 hippocampal neuronal model
Antiproliferative, DNA hypermethylation and 
oxidative stress damage
[29]
Mouse embryonic stem cells Transcriptomic alterations [30]
Bovine retinal endothelia Angiogenesis inhibition [32]
Erythrina indica extract
MCF7 breast cancer
Cytotoxic
[27]
HepG2 hepatocellular carcinoma
Albizia adianthifolia extract A549 lung cancer [61]
Acalypha indica extract MDA-MB-231 human breast adenocarcinoma Cytotoxic, proapoptotic [58]
AuNPs Naked HeLa cervical carcinoma
Cytotoxic [3, 36–38]PC-3 prostate cancer
HepG2 hepatocellular carcinoma
MDA-MB-231 human breast adenocarcinoma
Calu-1 epidermoid carcinoma
Proapoptotic, synergistic effect with 
anticancer molecules, DNA fragmentation and 
mitochondrial fission
[39]
MG63 osteosarcoma
Cytoskeleton damage in combination with laser 
treatment
[41]
A549 lung cancer
Cytoskeleton damage in combination with 
ultrasound
[42]
U251 glioblastoma Proapoptotic, radiosensitizer [43, 44]
HT-29 colon adenocarcinoma
Platinum coated MCF7 breast cancer
Proapoptotic, ROS production and cell cycle 
arrest
[47]
Acalypha indica extract MDA-MB-231 human breast adenocarcinoma Cytotoxic, proapoptotic [58]
PtNPs Naked A549 lung cancer
Cytotoxic [45]PA-1 human ovarian teratocarcinoma
Mia-Pa-Ca-2 human pancreas carcinoma
U118/U87 human malignant glioma Antiproliferative [46]
Neuro-2a brain neuroblastoma
Proapoptotic in combination with laser 
treatment
[48]
Cytotoxic and Antiproliferative Effects of Nanomaterials on Cancer Cell Lines: A Review
http://dx.doi.org/10.5772/intechopen.71685
75
Type Nanoparticles Coating material Cell type Biological effect Ref.
Cuprous oxide 
CONPs Naked
SiHa cervical squamous carcinoma
Cytotoxic, autophagy and proapoptotic [51]HeLa cervical carcinoma
MS751 cervical cancer
LNCaP FGC human prostate carcinoma
Cytotoxic, reduction in transcription factors for 
proliferation
[52]PC-3 prostate cancer
Metallic
DU145 prostate carcinoma
Iron oxide, 
SPIONs
Naked
U-2 OS osteosarcoma
Cytotoxic, autophagy and proapoptotic [53]
Saos-2 osteosarcoma
antiangiogenic peptide 
ATWLPPR (A7R) MDA-MB-231 human breast adenocarcinoma Reduce angiogenesis and proliferation [11]
ZnO Bovine serum albumin HepG2 hepatocellular carcinoma Anti-inflammatory and mitochondria-lysosome 
damage inducer
[79]
Nonmetallic
Biopolymer
4-hydroxytamoxifen and 
noncoding RNA (anti-miR-21)
MCF7, ZR-751, BT-474 breast cancer
Antiproliferative and proapoptotic [81]
4 T1 mouse mammary carcinoma
SiO
2
Naked Ø 12 nm GXF251L gastric carcinoma Increase proliferation [84]
Cerium oxide 
CeO Naked HT29 human colorectal adenocarcinoma Cytotoxic, antiproliferative and proapoptotic [85]
Cytochrome 
C (Cyt C) and 
hyaluronic acid 
(HA)
Naked A549 lung cancer Antiproliferative [87]
Liposomes
Core: Na3 
[1-(2′-B10H9)-2-
NH3B10H8]
Cholesterol, 1, 2-distearoyl-
sn-glycero-3-phosphocholine, 
K [nido-7-CH
3
 (CH
2
)15–7, 
8-C
2
B
9
H
11
]
EMT6 breast carcinoma
Increase radiosensitivity of tumors [89]
CT26 colon carcinoma
Lipid-core
Poly(ε-caprolactone), capric/
caprylic triglyceride, sorbitan 
monostearate and polysorbate 
80
SK-Mel-28 human melanoma Cytotoxic, proapoptotic and cell cycle arrest [92]
Table 2. Biological effects of different types of nanoparticles (NPs) on cancer cells.
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The results showed a 50% tumor reduction after 45 min of radiation, despite lower boron con-
centrations inside EMT6 tumor, in comparison to CT26. The average time for tumor growth, 
set as three times the pretreatment volume, was 38 days for BNCT-treated mice in comparison 
to 4 days for untreated controls. In conclusion, the authors found that liposomes were useful 
elements for increasing inherent radiosensitivity in selected tumors [89].
The use of liposomes has also been found useful for drug delivery systems [90]. Sadhu, et al. 
evaluated the cytotoxicity and antiproliferative effects of liposomes designed to increase the 
intracellular glutathione disulfide (GSSG) on B16 murine metastatic melanoma tumor cells 
(B16F10), human metastatic lung carcinoma cells (NCI-H226) and in vivo on C57BL/6 mice. 
Glutathione (GSH) is fundamental in the antioxidant defense against ROS [91]. Oxidation of 
GSH is mediated by a sulfhydryl residue from oxidative species and results in GSSG [91]. 
Analysis of GSSG has been a challenge since it is not inducible and neither cell membrane 
permeant. The results showed an important effect in the apoptotic pathway affecting cell 
migration, invasion and adhesion. Dacarbazine (the treatment option for melanoma) and 
GSSG liposomes showed a significant in vivo reduction of tumor proliferation (90% and 85%, 
respectively) [91].
Drewes, et al. demonstrated that lipid-core nanocapsules containing poly(ε-caprolactone), 
capric/caprylic triglyceride, sorbitan monostearate and polysorbate 80 affected cell prolif-
eration and triggered cell cycle arrest on SK-Mel-28 human melanoma cells. Furthermore, 
nanocapsules induced apoptosis and necrosis on a murine model B16F10 (H2b) bearing B16 
melanoma cell line [92]. To sum up, GSSG liposomes and lipid-core nanocapsules are poten-
tially useful for antimetastatic treatment and as drug delivery systems for melanoma treat-
ment, respectively [91]. Organically coated nanostructures, including liposomes, might exert 
antiproliferative cytotoxic properties against cancer cells/tumors but may also induce cell pro-
liferation depending on the type of tumor and nanostructure used.
The wide spectrum of known cancer cellular responses to nanomaterials is summarized in 
Table 2.
4. Conclusion
In vitro cellular models for the study of antiproliferative and/or cytotoxic properties of engi-
neered nanomaterials are valuable tools in cancer research. Cancer cell lines represent very 
easy-to-use models where different codelivery treatments might be tested. For instance, 
including chemotherapeutic drugs, siRNAs and antibodies in the same NPs should help 
lower drug concentrations and side effects as well as improve the therapeutic effect. Taking 
advantage of this type of approach in cancer cell lines might be of value when testing NPs 
in personalized medicine applications, when tumor cells from the patients are collected and 
either cultured or injected into in vivo vertebrate models. Recently, Rita, et al. reported the 
use of zebrafish xenotransplants [93] using colon cancer cell lines, SW480, SW620, and HT29, 
HCT116 and Hke3. Larvae were injected with cancer cells to develop mono-/polyclonal tumors, 
which were treated with different antiproliferation drugs. Results displayed differential 
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drug sensitivities and support the potential application of this assay in personalized medicine 
and diagnostics. Such approaches should also decrease multidrug resistance rates.
Several techniques and methods are readily available for investigation of nanostructured par-
ticle properties regarding their selective cytotoxicity and/or antiproliferative effects. Setting 
up of those techniques, however, needs to be carefully monitored. Harmonization of the wide 
range of methods available is necessary for assay comparison and replicability.
To sum up, extended cell-based testing (in vivo) is necessary to obtain a complete understand-
ing of the in vitro results. Although individual or core laboratory capabilities play a role in 
selection and availability of techniques, data arising from cancer cell models have demon-
strated usefulness in guiding further research.
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